- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dasatinib Placebo
Total 54972 results
-
GlaxoSmithKlineCompletedNeoplasms, Head and NeckSpain, Estonia, Italy, Philippines, Thailand, Germany, United States, Hong Kong, Ireland, China, United Kingdom, Argentina, Austria, Russian Federation, Czech Republic, Hungary, India, France, Canada, Croatia, Greece, Slovakia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Massachusetts General Hospital; Washington University School of Medicine; Gla... and other collaboratorsCompletedNeurofibromatosis 2 | Vestibular Schwannoma | Acoustic Neuroma | NF2 | Auditory TumorUnited States
-
Boehringer IngelheimTerminatedHead and Neck NeoplasmsUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, Egypt, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Netherlands, Portugal, Russian Federation, Spain, Sweden, Switzerlan... and more
-
Versailles HospitalUniversity Hospital, Bordeaux; Maisonneuve-Rosemont HospitalCompletedChronic Myelogenous Leukemia, BCR/ABL PositiveFrance, Canada
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | Non-small Cell Lung CancerChina
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
Nanfang Hospital of Southern Medical UniversityRecruitingLeukemia | Leukemia, B-cell | Leukemia, Acute | Leukemia, LymphoblasticChina
-
Mayo ClinicEnrolling by invitation
-
Radiation Therapy Oncology GroupGlaxoSmithKline; NovartisCompletedNon-HPV Locally Advanced Head and Neck CancerUnited States, Canada
-
Duke UniversityBristol-Myers SquibbTerminatedPancreatic Adenocarcinoma | Refractory Solid TumorsUnited States
-
AA SecordCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedProstate CancerUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingPrecursor Cell Lymphoblastic Leukemia-Lymphoma | ALL, Adult | Philadelphia-Positive Acute Lymphoblastic LeukemiaChina
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerChina
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingGestational Trophoblastic NeoplasiaChina
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Stanford UniversityKite PharmaRecruitingLymphoblastic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedMultiple Indications CancerFrance, Poland
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Shanghai Chest HospitalUnknownRecurrence | Metastasis | Esophageal Squamous Cell Carcinoma | ApatinibChina
-
Boehringer IngelheimApproved for marketing
-
Jian FangPeking University First Hospital; Peking University Third Hospital; The Second...Unknown
-
Jiangsu HengRui Medicine Co., Ltd.Fudan UniversityCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia | Dasatinib | BCR-ABLChina
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Netherlands, Spain, United States, Italy, Canada, France, Germany, Peru, Singapore, United Kingdom, Australia, Sweden, Finland, Israel, Ireland, Denmark, Korea, Republic of, Norway, Austria, South Africa, Switzerland
-
Consorzio OncotechUnknown
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, Canada
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
Hung-Hsueh ChouBristol-Myers Squibb; GlaxoSmithKlineUnknown
-
GlaxoSmithKlineCompletedAdenocarcinomaNetherlands, United States, Peru
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastUnited States
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
National Cancer Institute (NCI)NCIC Clinical Trials GroupCompletedBrain and Central Nervous System TumorsCanada
-
GlaxoSmithKlineCompleted
-
Brown UniversityRhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedA Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerUnited States
-
Third Military Medical UniversityNot yet recruiting
-
AB ScienceCompletedIndolent Systemic MastocytosisFrance, United States
-
Creighton UniversityNovartisUnknown
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGreece
-
Boehringer IngelheimCompletedNeuroectodermal Tumors | RhabdomyosarcomaUnited States, Spain, Canada, Germany, Italy, United Kingdom, Australia, Austria, Denmark, Faroe Islands, France, Netherlands